BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

689 related articles for article (PubMed ID: 9040461)

  • 1. Correlation of anterior chamber-associated immune deviation with suppression of corneal epithelial rejection in mice.
    Yao YF; Inoue Y; Miyazaki D; Hara Y; Shimomura Y; Tano Y; Ohashi Y
    Invest Ophthalmol Vis Sci; 1997 Feb; 38(2):292-300. PubMed ID: 9040461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The antigen-bearing eye and the spleen are indispensable in maintaining anterior chamber-associated immune deviation.
    Yao YF; Inoue Y; Miyazaki D; Hara Y; Shimomura Y; Tano Y; Ohashi Y
    Invest Ophthalmol Vis Sci; 1997 Feb; 38(2):534-9. PubMed ID: 9040487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-cell-mediated immune responses in alloepithelial rejection after murine keratoepithelioplasty.
    Miyazaki D; Inoue Y; Yao YF; Okada AA; Shimomura Y; Hayashi K; Tano Y; Ohashi Y
    Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2590-7. PubMed ID: 10509654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anterior chamber inoculation of splenocytes without Fas/Fas-ligand interaction primes for a delayed-type hypersensitivity response rather than inducing anterior chamber-associated immune deviation.
    Kawashima H; Yamagami S; Tsuru T; Gregerson DS
    Eur J Immunol; 1997 Oct; 27(10):2490-4. PubMed ID: 9368601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ocular resurfacing and alloepithelial rejection in a murine keratoepithelioplasty model.
    Yao YF; Inoue Y; Miyazaki D; Shimomura Y; Ohashi Y; Tano Y
    Invest Ophthalmol Vis Sci; 1995 Dec; 36(13):2623-33. PubMed ID: 7499085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of anterior chamber-associated immune deviation by corneal allografts placed in the anterior chamber.
    Yamada J; Streilein JW
    Invest Ophthalmol Vis Sci; 1997 Dec; 38(13):2833-43. PubMed ID: 9418737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of graft rejection in rat keratoepithelioplasty by anterior chamber inoculation of donor lymphocytes.
    Yao YF; Inoue Y; Hara Y; Kiritoshi A; Tano Y; Ohashi Y
    Jpn J Ophthalmol; 1994; 38(4):345-52. PubMed ID: 7723200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-1 receptor antagonist therapy and induction of anterior chamber-associated immune deviation-type tolerance after corneal transplantation.
    Yamada J; Zhu SN; Streilein JW; Dana MR
    Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4203-8. PubMed ID: 11095616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of tumor necrosis factor receptor expression in anterior chamber-associated immune deviation (ACAID) and corneal allograft survival.
    Niederkorn JY; Mayhew E; Mellon J; Hegde S
    Invest Ophthalmol Vis Sci; 2004 Aug; 45(8):2674-81. PubMed ID: 15277491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anterior chamber-associated immune deviation promotes corneal allograft survival.
    Niederkorn JY; Mellon J
    Invest Ophthalmol Vis Sci; 1996 Dec; 37(13):2700-7. PubMed ID: 8977485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the suppressor cell(s) responsible for anterior chamber-associated immune deviation (ACAID) induced in BALB/c mice by P815 cells.
    Streilein JW; Niederkorn JY
    J Immunol; 1985 Mar; 134(3):1381-7. PubMed ID: 3155766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of cyclosporine on anterior chamber-associated immune deviation with retinal transplantation.
    Ishioka M; Okamoto S; Streilein JW; Jiang LQ
    Invest Ophthalmol Vis Sci; 1997 Sep; 38(10):2152-60. PubMed ID: 9331279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preservation of donor cornea prevents corneal allograft rejection by inhibiting induction of alloimmunity.
    Kamiya K; Hori J; Kagaya F; Usui T; Amano S; Oshika T; Mizouchi T; Tsuru T; Yamagami S
    Exp Eye Res; 2000 Jun; 70(6):737-43. PubMed ID: 10843778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of CD4+ T cells in immunobiology of orthotopic corneal transplants in mice.
    Yamada J; Kurimoto I; Streilein JW
    Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2614-21. PubMed ID: 10509657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T-cell mediated responses in a murine model of orthotopic corneal transplantation.
    Joo CK; Pepose JS; Stuart PM
    Invest Ophthalmol Vis Sci; 1995 Jul; 36(8):1530-40. PubMed ID: 7601633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunologic mechanisms of corneal allografts reconstituted from cultured allogeneic endothelial cells in an immune-privileged site.
    Hayashi T; Yamagami S; Tanaka K; Yokoo S; Usui T; Amano S; Mizuki N
    Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3151-8. PubMed ID: 19255161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implication for the CD94/NKG2A-Qa-1 system in the generation and function of ocular-induced splenic CD8+ regulatory T cells.
    Chattopadhyay S; O'Rourke J; Cone RE
    Int Immunol; 2008 Apr; 20(4):509-16. PubMed ID: 18359787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of splenic B cells in the immune privilege of the anterior chamber of the eye.
    Niederkorn JY; Mayhew E
    Eur J Immunol; 1995 Oct; 25(10):2783-7. PubMed ID: 7589072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased expression of Foxp3 in splenic CD8+ T cells from mice with anterior chamber-associated immune deviation.
    Jiang L; Yang P; He H; Li B; Lin X; Hou S; Zhou H; Huang X; Aize K
    Mol Vis; 2007 Jun; 13():968-74. PubMed ID: 17653037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fate of orthotopic corneal allografts in eyes that cannot support anterior chamber-associated immune deviation induction.
    Sano Y; Ksander BR; Streilein JW
    Invest Ophthalmol Vis Sci; 1995 Oct; 36(11):2176-85. PubMed ID: 7558710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.